Blood Supply, Tissue Banking and Transplantation in United States: Daxor Corporation - Financial and Strategic Analysis Review

• Publication date: February 2009
• Report size: 18 pages

The industry player is headquartered in New York, United States and employs 40 people. Global Industry s Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis of Daxor Corporation. The report provides a comprehensive insight into the firm , including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strateg...

The industry player is headquartered in New York, United States and employs 40 people.

Global Industry s Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis of Daxor Corporation. The report provides a comprehensive insight into the firm , including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Industry s Direct’s views on the firm .

Scope of the Research

• The firm ’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the industry player are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical industry player information – business structure and operations, the industry player history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick “one-stop-shop” to understand the firm .
• Enhance business/sales activities by understanding customers’ businesses better.
• Get detailed information and financial & strategic analysis on industry players operating in your market .
• Identify prospective partners and suppliers – with key data on their businesses and locations.
• Capitalize on competitors’ weaknesses and target the industry opportunities available to them.
• Compare your firm ’s financial trends with those of your peers / competitors.
• Scout for potential take over targets, with detailed insight into the firms ’ strategic, financial and operational performance.

Blood Supply, Tissue Banking And Transplantation Industry in the United States

Table Of Contents
Key Information 1
Key Ratios 1
Share Data 1
Performance Chart 1
Table Of Contents 2
List of Tables 2
List of Figures 2
Key Facts 3
Business Description 3
Major Products and Services 4
Overview 4
SWOT Analysis Overview 5
Overview 5
Daxor Corporation - Strengths (SWOT Analysis) 5
BVA-100 Blood Volume Analyzer 5
Cryobanking Segment 5
Daxor Corporation - Weaknesses (SWOT Analysis) 5
Operating Losses 5
Dependence on the Customers 5
Daxor Corporation - Opportunities (SWOT Analysis) 5
Increasing Demand for LVAD 5
Scientific Studies Employing the BVA-100 6
Acquiring its Own Facility 6
Daxor Corporation - Threats (SWOT Analysis) 6
Dependence on Manufacturer 6
Rising Interest Rates 6
Changes in Reimbursement Policies 6
Key Competitors 7
Key Employees 7
Key Employee Biographies 8
Company Statement 10
Locations And Subsidiaries 11
Head Office 11
Financial Ratios 12
Capital March ket Ratios 12
Annual Ratios 12
Interim Ratios 13
Ratio Charts 14
Appendix 15
Methodology 15
Ratio Definitions 15
About Global March kets Direct 18
Contact Us 18
Disclaimer 18



List of Tables
Daxor Corporation, Key Facts, 2006 1
Daxor Corporation, Key Ratios 1
Daxor Corporation, Share Data 1
Daxor Corporation, Key Facts 3
Major Products and Services 4
Daxor Corporation, Key Employee Biographies 8
Currency Codes 15
Capital March ket Ratios 15
Equity Ratios 16
These ratios are based on per share value. 16
Profitability Ratios 16
Cost Ratios 17
Liquidity Ratios 17
Leverage Ratios 17
Efficiency Ratios 18



List of Figures
Daxor Corporation, Performance Chart (2003 - 2007) 1
Daxor Corporation, Ratio Charts 14